FREDUN

FREDUN PHARMACEUTICALS

Small Cap BSE: 539730 NSE: FREDUN
₹1328.00
17.95 (1.37%)
As on 30 November, 2022 | 15:17

Fredun Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in FREDUN PHARMACEUTICALS

Start SIP

Fredun Pharmaceuticals Share Price

Fredun Pharmaceuticals Share Returns

  • Over 1 Month 9.89%
  • Over 3 Month 13.54%
  • Over 6 Month 52.96%
  • Over 1 Year 175.12%

Fredun Pharmaceuticals Key Statistics

Fredun Pharmaceuticals Investment Rating

  • Master Rating:
  • Fredun Pharmaceuticals has an operating revenue of Rs. 239.54 Cr. on a trailing 12-month basis. An annual revenue growth of 67% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 9% is fair but needs improvement. The company has a debt to equity of 62%, which is bit higher. The stock from a technical standpoint is comfortably placed above its key moving averages, around 12% and 30% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 4% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 99 which is a GREAT score indicating consistency in earnings, a RS Rating of 86 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 123 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of A is the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock has great fundamentals and technical strength to stay in momentum.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Fredun Pharmaceuticals Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 69486953544541
Operating Expenses Qtr Cr 64456650514440
Operating Profit Qtr Cr 5433412
Depreciation Qtr Cr 1111111
Interest Qtr Cr 2221111
Tax Qtr Cr 1011100
Net Profit Qtr Cr 3122201

Fredun Pharmaceuticals Technicals

EMA & SMA

Current Price
1328.
17.95 (1.37%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 1234.18
  • 50 Day
  • 1178.26
  • 100 Day
  • 1110.99
  • 200 Day
  • 1005.23
  • 20 Day
  • 1262.75
  • 50 Day
  • 1159.75
  • 100 Day
  • 1076.69
  • 200 Day
  • 1003.53

Fredun Pharmaceuticals Resistance and Support

PIVOT
₹1308.
Resistance
First Resistance 1335.95
Second Resistance 1361.85
Third Resistance 1389.8
RSI 63.02
MFI 69.67
MACD Single Line 23.72
MACD 20.5
Support
First Resistance 1282.1
Second Resistance 1254.16
Third Resistance 1228.25

Fredun Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 6,361 481,082 75.63
Week 5,023 380,678 75.79
1 Month 3,056 230,054 75.29
6 Month 2,666 201,631 75.64

Fredun Pharmaceuticals Result Highlights

Fredun Pharmaceuticals Synopsis

BSE-Medical-Diversified

Fredun Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 224.46 Cr. and Equity Capital is Rs. 4.43 Cr. for the Year ended 31/03/2022. Fredun Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 08/06/1987 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1987PLC043662 and registration number is 043662.
Market Cap 600
Sales 240
Shares in Float 0.22
No of funds 1
Yield 0.05
Book Value 8.53
U/D Vol ratio 1.7
LTDebt / Equity 62
Alpha 0.43
Beta 0.88

Fredun Pharmaceuticals

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 51.04%51.04%51.27%
Financial Institutions/ Banks 1.68%1.68%1.69%
Individual Investors 42.02%42.02%41.8%
Others 5.26%5.26%5.24%

Fredun Pharmaceuticals Management

Name Designation
Dr.(Mrs.) Daulat N Medhora Chairman & Jt. M. D
Mr. Fredun Medhora Managing Director & CFO
Mr. Nariman Medhora Non Executive Director
Dr. Chandrakant Shah Ind. Non-Executive Director
Dr. Rohinton Kanga Ind. Non-Executive Director
Dr. Aspi Raimalwala Ind. Non-Executive Director

Fredun Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Fredun Pharmaceuticals Corporate Action

Date Purpose Remarks
2022-11-10 Quarterly Results
2022-08-27 Preferential issue of shares
2022-08-12 Quarterly Results
2022-05-16 Audited Results & Final Dividend
2022-01-28 Quarterly Results

Fredun Pharmaceuticals FAQs

What is Share Price of Fredun Pharmaceuticals ?

Fredun Pharmaceuticals share price is ₹1328 As on 30 November, 2022 | 15:03

What is the Market Cap of Fredun Pharmaceuticals ?

The Market Cap of Fredun Pharmaceuticals is ₹599.6 Cr As on 30 November, 2022 | 15:03

What is the P/E ratio of Fredun Pharmaceuticals ?

The P/E ratio of Fredun Pharmaceuticals is 71.6 As on 30 November, 2022 | 15:03

What is the PB ratio of Fredun Pharmaceuticals ?

The PB ratio of Fredun Pharmaceuticals is 8.7 As on 30 November, 2022 | 15:03

Q2FY23